Grant: Master's Award: Canada Graduate Scholarships
University of Calgary
$17,500.00
Opioid-Induced Adverse Events and Factors Associated with their Onset among Patients with Metastatic Cancer
EF 2022-23
Résumé
Background: Pain is a high priority concern for patients with cancer and its treatment is centred on the use of opioids. However, patients commonly experience adverse effects related to opioid use, which need to be considered in addition to beneficial analgesic effects. Patients with metastatic cancer are often excluded from studies on opioid-induced adverse effects (OIAEs), in spite of their elevated pain experience. Information on the onset of OIAEs among patients with metastatic cancer is needed to understand optimal opioid prescribing practices and risk assessment for this population. Objectives: Our project will 1) investigate the onset of OIAEs following the receipt of opioid prescription among patients with metastatic cancer, 2) investigate association of identified OIAEs with patient-reported outcomes, and 3) determine whether a relationship exists between various opioid prescribing practices and the onset of OIAEs. Methods: Using detailed chart review, we will identify OIAEs among patients with metastatic disease. This information will be linked with patient-reported outcomes to determine the association between physician-recorded OIAEs and patient-reported outcomes. Chart review data will be linked with administrative data to determine the association between prescription dosage, duration, and the onset of different types of OIAEs, as well as opioid-related hospitalizations. Significance: Detailed information on OIAEs and factors related to their onset is useful for patients and physicians engaged in shared decision-making regarding pain management. Providing up-to-date real-world data on opioid prescribing and its risks is necessary to facilitate optimal pain management for this population, who are heavily burdened by pain and other cancer-related symptoms.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
486430
Name
Harsanyi Hannah
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Opioid-Induced Adverse Events and Factors Associated with their Onset among Patients with Metastatic Cancer
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Advanced Cancer; Cancer Pain; Metastatic Cancer; Opioid; Opioid Toxicity; Pain Management; Palliative Care; Patient-Centred Care; Patient-Reported Outcomes; Symptom Management
Abstract
Background: Pain is a high priority concern for patients with cancer and its treatment is centred on the use of opioids. However, patients commonly experience adverse effects related to opioid use, which need to be considered in addition to beneficial analgesic effects. Patients with metastatic cancer are often excluded from studies on opioid-induced adverse effects (OIAEs), in spite of their elevated pain experience. Information on the onset of OIAEs among patients with metastatic cancer is needed to understand optimal opioid prescribing practices and risk assessment for this population. Objectives: Our project will 1) investigate the onset of OIAEs following the receipt of opioid prescription among patients with metastatic cancer, 2) investigate association of identified OIAEs with patient-reported outcomes, and 3) determine whether a relationship exists between various opioid prescribing practices and the onset of OIAEs. Methods: Using detailed chart review, we will identify OIAEs among patients with metastatic disease. This information will be linked with patient-reported outcomes to determine the association between physician-recorded OIAEs and patient-reported outcomes. Chart review data will be linked with administrative data to determine the association between prescription dosage, duration, and the onset of different types of OIAEs, as well as opioid-related hospitalizations. Significance: Detailed information on OIAEs and factors related to their onset is useful for patients and physicians engaged in shared decision-making regarding pain management. Providing up-to-date real-world data on opioid prescribing and its risks is necessary to facilitate optimal pain management for this population, who are heavily burdened by pain and other cancer-related symptoms.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Harsanyi, Hannah
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~